Literature DB >> 21773684

C-peptide reduces high-glucose-induced apoptosis of endothelial cells and decreases NAD(P)H-oxidase reactive oxygen species generation in human aortic endothelial cells.

V Cifarelli1, X Geng, A Styche, R Lakomy, M Trucco, P Luppi.   

Abstract

AIMS/HYPOTHESIS: Reactive oxygen species (ROS) generated during hyperglycaemia are implicated in the development of diabetic vascular complications. High glucose increases oxidative stress in endothelial cells and induces apoptosis. A major source of ROS in endothelial cells exposed to glucose is the NAD(P)H oxidase enzyme. Several studies demonstrated that C-peptide, the product of proinsulin cleavage within the pancreatic beta cells, displays anti-inflammatory effects in certain models of vascular dysfunction. However, the molecular mechanism underlying this effect is unclear. We hypothesised that C-peptide reduces glucose-induced ROS generation by decreasing NAD(P)H oxidase activation and prevents apoptosis
METHODS: Human aortic endothelial cells (HAEC) were exposed to 25 mmol/l glucose in the presence or absence of C-peptide and tested for protein quantity and activity of caspase-3 and other apoptosis markers by ELISA, TUNEL and immunoblotting. Intracellular ROS were measured by flow cytometry using the ROS sensitive dye chloromethyl-2',7'-dichlorodihydrofluorescein diacetate (CM-H(2)-DCDFA). NAD(P)H oxidase activation was assayed by lucigenin. Membrane and cytoplasmic levels of the NAD(P)H subunit ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) (RAC-1) and its GTPase activity were studied by immunoblotting and ELISA. RAC-1 (also known as RAC1) gene expression was investigated by quantitative real-time PCR.
RESULTS: C-peptide significantly decreased caspase-3 levels and activity and upregulated production of the anti-apoptotic factor B cell CLL/lymphoma 2 (BCL-2). Glucose-induced ROS production was quenched by C-peptide and this was associated with a decreased NAD(P)H oxidase activity and reduced RAC-1 membrane production and GTPase activity. CONCLUSIONS/
INTERPRETATION: In glucose-exposed endothelial cells, C-peptide acts as an endogenous antioxidant molecule by reducing RAC-1 translocation to membrane and NAD(P)H oxidase activation. By preventing oxidative stress, C-peptide protects endothelial cells from glucose-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21773684     DOI: 10.1007/s00125-011-2251-0

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  49 in total

1.  Higher post-absorptive C-peptide levels in Type 1 diabetic patients without renal complications.

Authors:  G Zerbini; R Mangili; L Luzi
Journal:  Diabet Med       Date:  1999-12       Impact factor: 4.359

Review 2.  Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB.

Authors:  Y M Janssen-Heininger; M E Poynter; P A Baeuerle
Journal:  Free Radic Biol Med       Date:  2000-05-01       Impact factor: 7.376

3.  C-peptide exerts cardioprotective effects in myocardial ischemia-reperfusion.

Authors:  L H Young; Y Ikeda; R Scalia; A M Lefer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-10       Impact factor: 4.733

4.  International trial of the Edmonton protocol for islet transplantation.

Authors:  A M James Shapiro; Camillo Ricordi; Bernhard J Hering; Hugh Auchincloss; Robert Lindblad; R Paul Robertson; Antonio Secchi; Mathias D Brendel; Thierry Berney; Daniel C Brennan; Enrico Cagliero; Rodolfo Alejandro; Edmond A Ryan; Barbara DiMercurio; Philippe Morel; Kenneth S Polonsky; Jo-Anna Reems; Reinhard G Bretzel; Federico Bertuzzi; Tatiana Froud; Raja Kandaswamy; David E R Sutherland; George Eisenbarth; Miriam Segal; Jutta Preiksaitis; Gregory S Korbutt; Franca B Barton; Lisa Viviano; Vicki Seyfert-Margolis; Jeffrey Bluestone; Jonathan R T Lakey
Journal:  N Engl J Med       Date:  2006-09-28       Impact factor: 91.245

5.  Human monocytes use Rac1, not Rac2, in the NADPH oxidase complex.

Authors:  Xiaoxian Zhao; Kevin A Carnevale; Martha K Cathcart
Journal:  J Biol Chem       Date:  2003-08-11       Impact factor: 5.157

6.  Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications.

Authors:  Pilar Martín-Gallán; Antonio Carrascosa; Miguel Gussinyé; Carmen Domínguez
Journal:  Free Radic Biol Med       Date:  2003-06-15       Impact factor: 7.376

7.  Vitamin E consumption and the risk of coronary disease in women.

Authors:  M J Stampfer; C H Hennekens; J E Manson; G A Colditz; B Rosner; W C Willett
Journal:  N Engl J Med       Date:  1993-05-20       Impact factor: 91.245

8.  Sequential abnormalities in type 1 diabetic encephalopathy and the effects of C-Peptide.

Authors:  Anders A F Sima; Weixian Zhang; Otto Muzik; Christian W Kreipke; José A Rafols; William H Hoffman
Journal:  Rev Diabet Stud       Date:  2009-11-10

9.  Metformin prevents glucose-induced protein kinase C-beta2 activation in human umbilical vein endothelial cells through an antioxidant mechanism.

Authors:  Alessandra Gallo; Giulio Ceolotto; Paolo Pinton; Elisabetta Iori; Ellen Murphy; Guy A Rutter; Rosario Rizzuto; Andrea Semplicini; Angelo Avogaro
Journal:  Diabetes       Date:  2005-04       Impact factor: 9.461

10.  Fasting plasma C-peptide and micro- and macrovascular complications in a large clinic-based cohort of type 1 diabetic patients.

Authors:  Francesco Panero; Giulia Novelli; Chiara Zucco; Paolo Fornengo; Massimo Perotto; Olivia Segre; Giorgio Grassi; Paolo Cavallo-Perin; Graziella Bruno
Journal:  Diabetes Care       Date:  2008-11-18       Impact factor: 17.152

View more
  27 in total

1.  Berberine improves mesenteric artery insulin sensitivity through up-regulating insulin receptor-mediated signalling in diabetic rats.

Authors:  Feng-Hao Geng; Guo-Hua Li; Xing Zhang; Peng Zhang; Ming-Qing Dong; Zhi-Jing Zhao; Yuan Zhang; Ling Dong; Feng Gao
Journal:  Br J Pharmacol       Date:  2016-04-05       Impact factor: 8.739

Review 2.  Current approaches in regenerative medicine for the treatment of diabetes: introducing CRISPR/CAS9 technology and the case for non-embryonic stem cell therapy.

Authors:  Lauren Coombe; Aamir Kadri; Jessica Ferrer Martinez; Vivas Tatachar; Gary Ian Gallicano
Journal:  Am J Stem Cells       Date:  2018-12-01

3.  C-peptide reduces pro-inflammatory cytokine secretion in LPS-stimulated U937 monocytes in condition of hyperglycemia.

Authors:  Jaime Haidet; Vincenza Cifarelli; Massimo Trucco; Patrizia Luppi
Journal:  Inflamm Res       Date:  2011-09-27       Impact factor: 4.575

Review 4.  The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: an update.

Authors:  Hanrui Zhang; Kevin C Dellsperger; Cuihua Zhang
Journal:  Basic Res Cardiol       Date:  2011-12-22       Impact factor: 17.165

Review 5.  C-Peptide and its career from innocent bystander to active player in diabetic atherogenesis.

Authors:  Corinna Lebherz; Nikolaus Marx
Journal:  Curr Atheroscler Rep       Date:  2013-07       Impact factor: 5.113

Review 6.  Mitochondrial hormesis and diabetic complications.

Authors:  Kumar Sharma
Journal:  Diabetes       Date:  2015-03       Impact factor: 9.461

7.  Association of blood glucose control and pancreatic reserve with diabetic retinopathy in the Veterans Affairs Diabetes Trial (VADT).

Authors:  Nasrin Azad; Lily Agrawal; Nicholas V Emanuele; Ronald Klein; Gideon D Bahn; Peter Reaven
Journal:  Diabetologia       Date:  2014-03-06       Impact factor: 10.122

Review 8.  Physiological effects and therapeutic potential of proinsulin C-peptide.

Authors:  Gina L C Yosten; Christine Maric-Bilkan; Patrizia Luppi; John Wahren
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-09-23       Impact factor: 4.310

9.  C-peptide prevents hyperglycemia-induced endothelial apoptosis through inhibition of reactive oxygen species-mediated transglutaminase 2 activation.

Authors:  Mahendra Prasad Bhatt; Young-Cheol Lim; JongYun Hwang; SungHun Na; Young-Myeong Kim; Kwon-Soo Ha
Journal:  Diabetes       Date:  2012-08-24       Impact factor: 9.461

10.  C-peptide levels are associated with mortality and cardiovascular mortality in patients undergoing angiography: the LURIC study.

Authors:  Nikolaus Marx; Guenther Silbernagel; Vincent Brandenburg; Mathias Burgmaier; Marcus E Kleber; Tanja B Grammer; Bernhard R Winkelmann; Bernhard O Boehm; Winfried März
Journal:  Diabetes Care       Date:  2012-11-30       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.